155 related articles for article (PubMed ID: 37137330)
1. Comparison of Performances among Four Bleeding-Prediction Scores in Elderly Cancer Patients with Venous Thromboembolism.
Xi S; Liu C; Yu S; Qiu J; He S; Yi Z
Hamostaseologie; 2023 Aug; 43(4):281-288. PubMed ID: 37137330
[TBL] [Abstract][Full Text] [Related]
2. Prognosis in patients with cancer-associated venous thromboembolism: Comparison of the RIETE-VTE and modified Ottawa score.
Pfaundler N; Limacher A; Stalder O; Méan M; Rodondi N; Baumgartner C; Aujesky D
J Thromb Haemost; 2020 May; 18(5):1154-1161. PubMed ID: 32124545
[TBL] [Abstract][Full Text] [Related]
3. Prospective, multicenter validation of prediction scores for major bleeding in elderly patients with venous thromboembolism.
Scherz N; Méan M; Limacher A; Righini M; Jaeger K; Beer HJ; Frauchiger B; Osterwalder J; Kucher N; Matter CM; Banyai M; Angelillo-Scherrer A; Lämmle B; Husmann M; Egloff M; Aschwanden M; Bounameaux H; Cornuz J; Rodondi N; Aujesky D
J Thromb Haemost; 2013 Mar; 11(3):435-43. PubMed ID: 23279158
[TBL] [Abstract][Full Text] [Related]
4. Predicting recurrences or major bleeding in cancer patients with venous thromboembolism. Findings from the RIETE Registry.
Trujillo-Santos J; Nieto JA; Tiberio G; Piccioli A; Di Micco P; Prandoni P; Monreal M;
Thromb Haemost; 2008 Sep; 100(3):435-9. PubMed ID: 18766259
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Bleeding Risk Scores in Elderly Patients Receiving Extended Anticoagulation with Vitamin K Antagonists for Venous Thromboembolism.
Frei AN; Stalder O; Limacher A; Méan M; Baumgartner C; Rodondi N; Aujesky D
Thromb Haemost; 2021 Nov; 121(11):1512-1522. PubMed ID: 33930905
[TBL] [Abstract][Full Text] [Related]
6. External validation of the VTE-BLEED score for predicting major bleeding in stable anticoagulated patients with venous thromboembolism.
Klok FA; Barco S; Konstantinides SV
Thromb Haemost; 2017 Jun; 117(6):1164-1170. PubMed ID: 28276566
[TBL] [Abstract][Full Text] [Related]
7. Prediction of major bleeding in patients receiving DOACs for venous thromboembolism: A prospective cohort study.
Vedovati MC; Mancuso A; Pierpaoli L; Paliani U; Conti S; Ascani A; Galeotti G; Di Filippo F; Caponi C; Agnelli G; Becattini C
Int J Cardiol; 2020 Feb; 301():167-172. PubMed ID: 31761402
[TBL] [Abstract][Full Text] [Related]
8. Estimating Bleeding Risk in Patients with Cancer-Associated Thrombosis: Evaluation of Existing Risk Scores and Development of a New Risk Score.
de Winter MA; Dorresteijn JAN; Ageno W; Ay C; Beyer-Westendorf J; Coppens M; Klok FA; Moustafa F; Riva N; Ruiz Artacho PC; Vanassche T; Nijkeuter M
Thromb Haemost; 2022 May; 122(5):818-829. PubMed ID: 34544170
[TBL] [Abstract][Full Text] [Related]
9. Comparison of four scores to predict major bleeding in patients receiving anticoagulation for venous thromboembolism: findings from the RIETE registry.
Piovella C; Dalla Valle F; Trujillo-Santos J; Pesavento R; López L; Font L; Valle R; Nauffal D; Monreal M; Prandoni P;
Intern Emerg Med; 2014 Dec; 9(8):847-52. PubMed ID: 24839226
[TBL] [Abstract][Full Text] [Related]
10. Prediction of Major Bleeding in Anticoagulated Patients for Venous Thromboembolism: Comparison of the RIETE and the VTE-BLEED Scores.
Lecumberri R; Jiménez L; Ruiz-Artacho P; Nieto JA; Ruiz-Giménez N; Visonà A; Skride A; Moustafa F; Trujillo J; Monreal M;
TH Open; 2021 Jul; 5(3):e319-e328. PubMed ID: 34568742
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of venous thromboembolism (VTE)-BLEED to predict major bleeding and other adverse events in a practice-based cohort of patients with VTE: results of the XALIA study.
Klok FA; Barco S; Turpie AGG; Haas S; Kreutz R; Mantovani LG; Gebel M; Herpers M; Bugge JP; Kostantinides SV; Ageno W
Br J Haematol; 2018 Nov; 183(3):457-465. PubMed ID: 30123981
[TBL] [Abstract][Full Text] [Related]
12. Risk Scores for Occult Cancer in Patients with Venous Thromboembolism: A Post Hoc Analysis of the Hokusai-VTE Study.
Kraaijpoel N; van Es N; Raskob GE; Büller HR; Carrier M; Zhang G; Lin M; Grosso MA; Di Nisio M
Thromb Haemost; 2018 Jul; 118(7):1270-1278. PubMed ID: 29864787
[TBL] [Abstract][Full Text] [Related]
13. Application of the RIETE score to identify low-risk patients with pulmonary embolism: From the COMMAND VTE Registry.
Tsujisaka Y; Yamashita Y; Morimoto T; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Chen PM; Murata K; Tsuyuki Y; Nishimoto Y; Sakamoto J; Togi K; Mabuchi H; Takabayashi K; Kato T; Ono K; Kimura T;
Thromb Res; 2023 Dec; 232():35-42. PubMed ID: 37922657
[TBL] [Abstract][Full Text] [Related]
14. Machine learning to predict major bleeding during anticoagulation for venous thromboembolism: possibilities and limitations.
Mora D; Mateo J; Nieto JA; Bikdeli B; Yamashita Y; Barco S; Jimenez D; Demelo-Rodriguez P; Rosa V; Yoo HHB; Sadeghipour P; Monreal M;
Br J Haematol; 2023 Jun; 201(5):971-981. PubMed ID: 36942630
[TBL] [Abstract][Full Text] [Related]
15. Association between anticoagulant treatment duration and risk of venous thromboembolism recurrence and bleeding in clinical practice.
Kaatz S; Fu AC; AbuDagga A; LaMori J; Bookhart BK; Damaraju CV; Tan H; Schein J; Nutescu E
Thromb Res; 2014 Oct; 134(4):807-13. PubMed ID: 25127013
[TBL] [Abstract][Full Text] [Related]
16. Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study.
Kraaijpoel N; Di Nisio M; Mulder FI; van Es N; Beyer-Westendorf J; Carrier M; Garcia D; Grosso M; Kakkar AK; Mercuri MF; Middeldorp S; Hernandez CR; Santamaria A; Schwocho L; Segers A; Verhamme P; Wang TF; Weitz JI; Zhang G; Zwicker JI; Büller HR; Raskob GE
Thromb Haemost; 2018 Aug; 118(8):1439-1449. PubMed ID: 30060256
[TBL] [Abstract][Full Text] [Related]
17. Poor predictive value of contemporary bleeding risk scores during long-term treatment of venous thromboembolism. A multicentre retrospective cohort study.
Riva N; Bellesini M; Di Minno MN; Mumoli N; Pomero F; Franchini M; Fantoni C; Lupoli R; Brondi B; Borretta V; Bonfanti C; Ageno W; Dentali F
Thromb Haemost; 2014 Sep; 112(3):511-21. PubMed ID: 24899092
[TBL] [Abstract][Full Text] [Related]
18. Low discriminating power of the modified Ottawa VTE risk score in a cohort of patients with cancer from the RIETE registry.
Alatri A; Mazzolai L; Font C; Tafur A; Valle R; Marchena PJ; Ballaz A; Tiraferri E; Font L; Monreal M; Riete Investigators T
Thromb Haemost; 2017 Jul; 117(8):1630-1636. PubMed ID: 28517021
[TBL] [Abstract][Full Text] [Related]
19. Predicting recurrences or major bleeding in women with cancer and venous thromboembolism. Findings from the RIETE Registry.
Trujillo-Santos J; Ruiz-Gamietea A; Luque JM; Samperiz AL; Garcia-Bragado F; Todoli JA; Monreal M;
Thromb Res; 2009; 123 Suppl 2():S10-5. PubMed ID: 19217463
[TBL] [Abstract][Full Text] [Related]
20. Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolism.
Wells PS; Tritschler T; Khan F; Anderson DR; Kahn SR; Lazo-Langner A; Carrier M; Le Gal G; Castellucci LA; Shah V; Kaatz S; Kearon C; Solymoss S; Zide R; Schulman S; Chagnon I; Mallick R; Rodger MA; Kovacs MJ
Blood Adv; 2022 Aug; 6(15):4605-4616. PubMed ID: 35679460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
